Influence of hemodialysis membrane type on pentosidine plasma level, a marker of 'carbonyl stress'

Kidney International

Volumn 55, Issue 6, 1999, Pages 2487-2492

  Jadoul, Michel ^a,b,c   Ueda, Yasuhiko ^a,b   Yasuda, Yoshinari ^a,b   Saito, Akira ^a,b   Robert, Annie ^a,b   Ishida, Naoto ^a,b   Kurokawa, Kiyoshi ^a,b   Van Ypersele De Strihou, Charles ^a,b   Miyata, Toshio ^a,b  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b University of Tokyo   (Japan)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Advanced glycation end products; AN69; Dialysis; High flux polysulfone; Low flux cellulose; Polymethylmethacrylate; Uremic toxicity

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBONYL DERIVATIVE; CELLULOSE; PENTOSIDINE; POLY(METHYL METHACRYLATE); POLYSULFONE;

ADULT; AGED; ARTICLE; BELGIUM; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS MEMBRANE; DIURESIS; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; UREMIA;

EID: 0032991596     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00468.x     Document Type: Article

References (17)

1. 1. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA: Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325:836-842, 1991
2. 2. Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H: Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. J Clin Invest 93:521-528, 1994
3. 3. Miyata T, Ueda Y, Yamada Y, Izuhara Y, Saito A, Jadoul M, Kurokawa K, Van Ypersele De Strihou C: Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: Carbonyl stress in uremia. J Am Soc Nephrol 9:2349-2356, 1998
4. 4. Miyata T, Van Ypersele De Strihou C, Kurokawa K, Baynes JW: Alterations in non-enzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. (Perspectives in Renal Medicine) Kidney Int 55:389-399, 1999
5. 5. Miyata T, Fu MX, Kurokawa K, Van Ypersele De Strihou C, Thorpe R, Baynes JW: Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: Is there oxidative stress in uremia? Kidney Int 54:1290-1295, 1998
6. 6. Miyata T, Wada Y, Cai Z, Iida Y, Horie K, Yasuda Y, Maeda K, Kurokawa K, Van Ypersele De Strihou C: Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 51:1170-1181, 1997
7. 7. Miyata T, Ueda Y, Iida Y, Tanaka S, Kurokawa K, Van Ypersele De Strihou C, Maeda K: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients: Renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 7:1198-1206, 1996
8. 8. BMDP: New System Professional Edition: Registered Trademark of Statistical Solutions Inc., Berkeley, University of California Press, 1995
9. 9. Miyata T, Ueda Y, Yoshida A, Sugiyama S, Iida Y, Jadoul M, Maeda K, Kurokawa K, Van Ypersele De Strihou C: Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. Kidney Int 51:880-887, 1997
10. 10. Loughrey CM, Young IS, Kightbody JH, McMaster D, McNamee Pt, Trimble ER: Oxidative stress in haemodialysis. Q J Med 87:679-683, 1994
11. 11. Ueda Y, Miyata T, Hashimoto T, Yamada H, Izuhara Y, Sakai H, Kurokawa K: Implications of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia. Biochem Biophys Res Commun 245:785-790, 1998
12. 12. Kumano K, Yokota S, Go M, Suyama K, Sakai T, Era S, Sogami M: Quantitative and qualitative changes of serum albumin in CAPD patients. Adv Perit Dial 8:127-130, 1992
13. 13. Witko-Sarsat V, Friedklander M, Capelleire,-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B: Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304-1313, 1996
14. 14. Hricik DE, Wu YC, Schulak JA, Friedlander MA: Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplant 10:568-573, 1996
15. 15. Kabanda A, Jadoul M, Pochet JM, Lauwerys R, Van Ypersele De Strihou C, Bernard A: Determinants of the serum concentrations of low molecular weight proteins in patients on maintenance hemodialysis. Kisdney Int 45:1689-1696, 1994
16. 16. Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, Van Ypersele De Strihou C, Kurokawa K: Renal catabolism of advanced glycation end products: The fate of pentosidine. Kidney Int 53:416-422, 1998
17. 17. Gugliucci A, Bandayan M: Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39:149-160, 1996